ACTN4 (actinin, alpha 4)
2013-04-01 Dimitar P Zankov  , Hisakazu Ogita   AffiliationDepartment of Biochemistry, Molecular Biology, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga 520-2192, Japan
Identity

DNA/RNA
Description
ACTN4 single nucleotide variants and insertions/deletions included in dbSNP137 (NCBI) count 1776 entities.
Transcription
Yeast two-hybrid screen of human cDNA library captured another splice variant lacking nt 263-1433 of the full-length mRNA thus removing part of the first and second calponin-homology domain, the first and partially second spectrin-like repeat from α-actinin 4 (Chakraborty et al., 2006).
Pseudogene
Proteins

Description
α-Actinin 4 is a ~100 kDa protein. It has high degree of similarity to α-actinin 1 isoforms: 87% identical to isoform b (NP_001093.1) and 85% to isoform a (NP_001123476.1). α-Actinin 4 is cloned and characterized by Honda et al. (1998) in cancer cells although earlier description of two non-muscle α-actinins in chick lung exists (Imamura and Masaki, 1992). All spectrin-related proteins share similar structure: N-terminal actin-binding site formed by a pair of calponin-homology domains, central rod domain containing variable number spectrin-like repeats and C-terminal calmodulin domain with two EF-hand motifs (Broderick and Winder, 2002). Human α-actinin harbors 4 spectrin repeats and functions as antiparallel homodimer so that N-terminal lateral domains effectively bundle the actin filaments. Surprisingly, very recent study has discovered α-actinin 1/α-actinin 4 heterodimers in several cancer cell lines (Foley and Young, 2013).
Expression
Localisation
Another characteristic residence of α-actinin 4 is peripheral and dorsal cell protrusions associated with cell movement (Araki et al., 2000). In the kidney α-actinin 4 is highly expressed and located in the foot processes of glomerular podocytes where it is essential for the kidney barrier function.
Function
i/ Cytoskeletal organization and cell motility. Ability of α-actinin 4 to crosslink actin stress fibers and binding of transmembrane proteins in the cell junctions contributes to the maintenance of cell shape and anchoring to the adjacent extracellular matrix. α-Actinin 4 is involved in targeting JRAB/MICAL-L2 complex (important for recycling of occludin) to plasma membrane of TJs and participates in TJ formation (Nakatsuji et al., 2008).
Together with α-actinin 1, α-actinin 4 is essential for the formation of dorsal stress fibers in the migrating cells, composition and maturation of focal adhesions. Tyrosine phosphorylation of α-actinins is critical in those processes. In the absence of α-actinins focal adhesions have reduced affinity to extracellular matrix proteins (Feng et al., 2013).
Expression of α-actinin 4 is upregulated in the migrating cells and localized in their protrusions (Honda et al., 1998). In the stepwise process of cell movement it is believed that α-actinin 4 (most probably both non-muscle isoforms) is important for the detachment of rear cell end through organized disassembly of focal adhesions by calpain (Bhatt et al., 2002; Shao et al., 2013). Complementary mechanism promoting focal adhesions disassembly is binding of PIP3, a lipid product of phoshoinositide 3-kinase, to the α-actinins CH2 domain. That interaction reduces affinity of α-actinins to actin and integrin (Greenwood et al., 2000).
ii/ Modulation of gene transcription. It has been shown that α-actinin 4 interacts with nuclear receptors (estrogen receptor α in MCF-7 cells, vitamin D receptor in CV-1 cells, retinoic acid receptor and peroxisome proliferator-activated receptor γ in podocytes) and transcriptional co-activators (PCAF, SRC-1) through its LXXLL motif (Khurana et al., 2012a; Khurana et al., 2012b). Binding affinity to the nuclear factors was stronger in the alternatively spliced (short) isoform identified in a human cDNA library during earlier study (Chakraborty et al., 2006). All the above interactions enhance gene transcription. In addition, α-actinin 4 antagonizes histone deacetylase 7 thereby potentiating myocyte enhancer factor-2 in HeLa cells (Khurana et al., 2011).
ACTN4 product also is transcriptional co-activator of RelA/p65 subunit of NF-kB (Aksenova et al., 2013). Together with nuclear factor-Y, α-actinin 4 modulates transcription of CYP1A1, gene involved in pathogenesis of certain cases of lung and breast cancer (Poch et al., 2004).
α-Actinin 4 interacts with INO80 chromatin-remodeling complex and promote Cyclin B1 expression. In the mitotic phase, α-actinin 4 associates with upstream binding factor-dependent transcriptional complex (Kumeta et al., 2010).
iii/ Apoptosis. Endonuclease DNaseY is involved in apoptotic DNA degradation. α-Actinin 4 physically associates with DNaseY and dramatically enhances activity of the enzyme and percentage of PC12 cells developing apoptosis induced by teniposide (Liu et al., 2004).
iv/ Clathrin-mediated endocytosis. α-Actinin has been found in isolated plasma membranes containing clathrin (Burridge et al., 1980) and association of α-actinin 4 and clathrin heavy chain has been identified in prostate cancer cells. Overexpression of α-actinin 4 facilitated transferrin endocytosis (Hara et al., 2007).
v/ Function in glomerular podocytes. The presence of intact α-actinin 4 in the foot processes of podocytes is vital for the proper glomerular filtration. Elimination of the gene function in animal experiments (ACTN4 knockout mice) and mutations in human ACTN4 result in the development of focal segmental glomerulosclerosis (Kos et al., 2003; Kaplan et al., 2000).
vi/ Other. Exhaustive listing of α-actinin 4 interactions is beyond the scope of this structured review article. More details can be found at least in several excellent review publications (Sjöblom et al., 2008; Otey and Carpen, 2004; Oikonomou et al., 2011).
Homology
Mutations
Note
Germinal
Somatic
Implicated in
Amplification of chromosome 19q13.1-q13.2 has been reported in pancreatic cancer-derived cell lines and pancreatic cancer tissue. ACTN4 is one of the putative oncogenes in that locus (Miwa et al., 1996; Höglund et al., 1998).
Using highly specific monoclonal antibody, alternatively spliced variant of ACTN4 has been identified exclusively in high-grade neuroendocrine lung tumors compared to non-neuroendocrine lung cancers, 96 of 176 (55%) versus 3 of 378 (0.8%) of investigated patients, respectively. Statistical analysis revealed that variant α-actinin 4 is independent negative prognostic factor. The protein binds F-actin with higher avidity (Miyanaga et al., 2013).
Analysis of gene expression by microarray technology proved α-actinin 4 as a marker of worse disease development in non-small cell lung cancer. Higher expression of α-actinin 4 has been correlated to significantly lower survival (Yamagata et al., 2003).
Small cell lung cancer (SCLC) cell lines and tissue from the patient biopsies express ACTN4 alternatively spliced variant, normally found in the testis. Variant α-actinin 4 binds F-actin with higher affinity. This splice variant was proposed as diagnostic marker in SCLC (Honda et al., 2004).
Immune response against the mutated ACTN4 in the patient with large cell lung cancer has been involved in the clinical evolution of the disease. Furthermore, after extraction of the primary tumor the cytotoxic T lymphocyte clone targeting mutated α-actinin 4 persisted many years in the patients blood (Echchakir et al., 2001). In the subsequent study, it has been shown that the above point mutation removes antiproliferative effect of ACTN4 protein in the cancer cell line and supports the notion that ACTN4 may be both tumor suppressor as well as tumor promoter gene (Menez et al., 2004).
However, some experimental data support the opposite concept: a number of cytoskeleton-associated proteins show reduced expression in cancer cells and recovering their levels (e.g., in vitro transfection) transform the cells phenotype to less malignant (Glück et al., 1993). Human neuroblastoma cell lines with high malignant phenotype express lower level of α-actinin 4 compared to more differentiated and less malignant neuroblastoma cell lines. Transfection with ACTN4 has suppressed tumorigenicity and has converted neuroblasts from high to low malignant phenotype. The effect persisted until the level of α-actinin 4 in transfected cells was maintained and initial high malignancy phenotype recovered when α-actinin 4 declined (Nikolopoulos et al, 2000).
ACTN4 is a candidate oncogene in epithelial ovarian cancer. In subset of patients it has been found that the chromosome 19q12-q13 region is amplified correlating with higher expression of α-actinin 4 protein (Yamamoto et al., 2009).
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 23482348 | 2013 | Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB. | Aksenova V et al |
| 10954430 | 2000 | Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages: analysis by fluorescence ratio imaging. | Araki N et al |
| 17062137 | 2006 | Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. | Becker-Merok A et al |
| 12154072 | 2002 | Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. | Bhatt A et al |
| 12064945 | 2002 | Towards a complete atomic structure of spectrin family proteins. | Broderick MJ et al |
| 7005908 | 1980 | The association of alpha-actinin and clathrin with the plasma membrane. | Burridge K et al |
| 16980305 | 2006 | Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7. | Chakraborty S et al |
| 10964513 | 2000 | Gene structure, chromosomal localization, and expression pattern of Capn12, a new member of the calpain large subunit gene family. | Dear TN et al |
| 11911890 | 2002 | The spectrin repeat: a structural platform for cytoskeletal protein assemblies. | Djinovic-Carugo K et al |
| 11358829 | 2001 | A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. | Echchakir H et al |
| 23454549 | 2013 | α-actinin1 and 4 tyrosine phosphorylation is critical for stress fiber establishment, maintenance and focal adhesion maturation. | Feng Y et al |
| 23557398 | 2013 | An analysis of splicing, actin-binding properties, heterodimerization and molecular interactions of the non-muscle α-actinins. | Foley KS et al |
| 17960614 | 2007 | Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. | Fu L et al |
| 8380636 | 1993 | Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA. | Glück U et al |
| 10931873 | 2000 | Restructuring of focal adhesion plaques by PI 3-kinase. Regulation by PtdIns (3,4,5)-p(3) binding to alpha-actinin. | Greenwood JA et al |
| 17001515 | 2006 | Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. | Guéguen P et al |
| 17151021 | 2007 | Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells. | Hara T et al |
| 9443037 | 1998 | Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: frequent loss of 19p13.3 and gain of 19q13.1-13.2. | Höglund M et al |
| 15633123 | 2005 | Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. | Honda K et al |
| 1334489 | 1992 | A novel nonmuscle alpha-actinin. Purification and characterization of chicken lung alpha-actinin. | Imamura M et al |
| 10700177 | 2000 | Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. | Kaplan JM et al |
| 22351778 | 2012 | Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. | Khurana S et al |
| 18765526 | 2008 | Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. | Kikuchi S et al |
| 19969329 | 2010 | The role of actinin-4 in bladder cancer invasion. | Koizumi T et al |
| 12782671 | 2003 | Mice deficient in alpha-actinin-4 have severe glomerular disease. | Kos CH et al |
| 20197409 | 2010 | Molecular mechanisms underlying nucleocytoplasmic shuttling of actinin-4. | Kumeta M et al |
| 19897525 | 2010 | Phylogenetic analysis of gene structure and alternative splicing in alpha-actinins. | Lek M et al |
| 15002038 | 2004 | Regulation of DNaseY activity by actinin-alpha4 during apoptosis. | Liu QY et al |
| 15048094 | 2004 | Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. | Menez J et al |
| 8780719 | 1996 | Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. | Miwa W et al |
| 22887464 | 2013 | Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours. | Miyanaga A et al |
| 11298348 | 2001 | Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. | Mostoslavsky G et al |
| 18332111 | 2008 | Involvement of actinin-4 in the recruitment of JRAB/MICAL-L2 to cell-cell junctions and the formation of functional tight junctions. | Nakatsuji H et al |
| 10656685 | 2000 | The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. | Nikolopoulos SN et al |
| 21241830 | 2011 | Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. | Oikonomou KG et al |
| 15083532 | 2004 | Alpha-actinin revisited: a fresh look at an old player. | Otey CA et al |
| 15364540 | 2004 | Two distinct classes of CCAAT box elements that bind nuclear factor-Y/alpha-actinin-4: potential role in human CYP1A1 regulation. | Poch MT et al |
| 20156433 | 2010 | Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. | Quick Q et al |
| 23466492 | 2013 | The carboxyl tail of alpha-actinin-4 regulates its susceptibility to m-calpain and thus functions in cell migration and spreading. | Shao H et al |
| 18488141 | 2008 | Alpha-actinin structure and regulation. | Sjöblom B et al |
| 15014165 | 2004 | Molecular evolution and structure of alpha-actinin. | Virel A et al |
| 14581339 | 2003 | A training-testing approach to the molecular classification of resected non-small cell lung cancer. | Yamagata N et al |
| 19151661 | 2009 | Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. | Yamamoto S et al |
| 15208719 | 2004 | Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. | Yao J et al |
| 16751418 | 2006 | Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin. | Zhao Z et al |
Other Information
Locus ID:
NCBI: 81
MIM: 604638
HGNC: 166
Ensembl: ENSG00000130402
Variants:
dbSNP: 81
ClinVar: 81
TCGA: ENSG00000130402
COSMIC: ACTN4
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37730132 | 2024 | Protein tyrosine phosphatase 1B is a regulator of alpha-actinin4 in the glomerular podocyte. | 0 |
| 38299456 | 2024 | Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen receptors. | 0 |
| 37730132 | 2024 | Protein tyrosine phosphatase 1B is a regulator of alpha-actinin4 in the glomerular podocyte. | 0 |
| 38299456 | 2024 | Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen receptors. | 0 |
| 36974749 | 2023 | Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension. | 2 |
| 37014572 | 2023 | Analysis of the association of NPHS2 and ACTN4 genes polymorphism with nephrotic syndrome in Egyptian children. | 0 |
| 37626047 | 2023 | PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway. | 0 |
| 36974749 | 2023 | Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension. | 2 |
| 37014572 | 2023 | Analysis of the association of NPHS2 and ACTN4 genes polymorphism with nephrotic syndrome in Egyptian children. | 0 |
| 37626047 | 2023 | PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway. | 0 |
| 34673139 | 2022 | C-Mannosylated tryptophan-containing WSPW peptide binds to actinin-4 and alters E-cadherin subcellular localization in lung epithelial-like A549 cells. | 0 |
| 35856314 | 2022 | Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p. | 3 |
| 36476259 | 2022 | Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells. | 1 |
| 34673139 | 2022 | C-Mannosylated tryptophan-containing WSPW peptide binds to actinin-4 and alters E-cadherin subcellular localization in lung epithelial-like A549 cells. | 0 |
| 35856314 | 2022 | Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p. | 3 |
Citation
Dimitar P Zankov ; Hisakazu Ogita
ACTN4 (actinin, alpha 4)
Atlas Genet Cytogenet Oncol Haematol. 2013-04-01
Online version: http://atlasgeneticsoncology.org/gene/562/actn4-(actinin-alpha-4)
